BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22142221)

  • 1. Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis.
    Cheng J; Liu J; Shi Z; Jules J; Xu D; Luo S; Wei S; Feng X
    J Interferon Cytokine Res; 2012 Jan; 32(1):34-45. PubMed ID: 22142221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis.
    Chen Y; Wang Y; Tang R; Yang J; Dou C; Dong Y; Sun D; Zhang C; Zhang L; Tang Y; Dai Q; Luo F; Xu J; Dong S
    Cell Death Dis; 2020 Jun; 11(6):414. PubMed ID: 32488049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
    Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
    J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLAT negatively regulates RANKL-induced osteoclast differentiation.
    Youn BU; Kim K; Kim JH; Lee J; Moon JB; Kim I; Park YW; Kim N
    Mol Cells; 2013 Sep; 36(3):252-7. PubMed ID: 23996528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-
    Lv ZT; Liang S; Chen K; Zhang JM; Cheng P; Guo JC; Yang Q; Zhou CH; Liao H; Chen AM
    Biomed Res Int; 2018; 2018():3936257. PubMed ID: 29977911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.
    Xia Y; Inoue K; Du Y; Baker SJ; Reddy EP; Greenblatt MB; Zhao B
    Nat Commun; 2022 Jul; 13(1):3920. PubMed ID: 35798734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine IRF8 Mutation Offers New Insight into Osteoclast and Root Resorption.
    Das A; Yesupatham SK; Allison D; Tanwar H; Gnanasekaran J; Kear B; Wang X; Wang S; Zachariadou C; Abbasi Y; Chung MK; Ozato K; Liu C; Foster BL; Thumbigere-Math V
    J Dent Res; 2024 Mar; 103(3):318-328. PubMed ID: 38343385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice.
    MacLauchlan S; Kushwaha P; Tai A; Chen S; Manning C; Swarnkar G; Abu-Amer Y; Fitzgerald KA; Sharma S; Gravallese EM
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2210409120. PubMed ID: 37023130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.
    Zheng T; Kang JH; Sim JS; Kim JW; Koh JT; Shin CS; Lim H; Yim M
    Oncotarget; 2017 Sep; 8(44):76558-76573. PubMed ID: 29100332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.
    Zheng J; He W; Chen Y; Li L; Liang Q; Dai W; Li R; Chen F; Chen Z; Tan Y; Li X
    J Adv Res; 2024 Mar; ():. PubMed ID: 38556044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption.
    Thumbigere-Math V; Foster BL; Bachu M; Yoshii H; Brooks SR; Coulter A; Chavez MB; Togi S; Neely AL; Deng Z; Mansky KC; Ozato K; Somerman MJ
    J Bone Miner Res; 2019 Jun; 34(6):1155-1168. PubMed ID: 30840779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL-induced M1 macrophages are involved in bone formation.
    Huang R; Wang X; Zhou Y; Xiao Y
    Bone Res; 2017; 5():17019. PubMed ID: 29263936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteo-immunological impact of radon spa treatment: due to radon or spa alone? Results from the prospective, thermal bath placebo-controlled RAD-ON02 trial.
    Eckert D; Evic M; Schang J; Isbruch M; Er M; Dörrschuck L; Rapp F; Donaubauer AJ; Gaipl US; Frey B; Fournier C
    Front Immunol; 2023; 14():1284609. PubMed ID: 38292488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology.
    Li S; Liu G; Hu S
    Front Immunol; 2024; 15():1396122. PubMed ID: 38817601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflamm-Aging-Related Cytokines of IL-17 and IFN-
    Tan J; Dai A; Pan L; Zhang L; Wang Z; Ke T; Sun W; Wu Y; Ding PH; Chen L
    J Immunol Res; 2021; 2021():9919024. PubMed ID: 34395635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence.
    Wong SK; Mohamad NV; Ibrahim N'; Chin KY; Shuid AN; Ima-Nirwana S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-Gamma-Mediated Osteoimmunology.
    Tang M; Tian L; Luo G; Yu X
    Front Immunol; 2018; 9():1508. PubMed ID: 30008722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ Released by Activated CD8
    Nagy E; Lei Y; Martínez-Martínez E; Body SC; Schlotter F; Creager M; Assmann A; Khabbaz K; Libby P; Hansson GK; Aikawa E
    Am J Pathol; 2017 Jun; 187(6):1413-1425. PubMed ID: 28431214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrasive Endoprosthetic Wear Particles Inhibit IFN-γ Secretion in Human Monocytes Via Upregulating TNF-α-Induced miR-29b.
    Bu YM; Zheng DZ; Wang L; Liu J
    Inflammation; 2017 Feb; 40(1):166-173. PubMed ID: 27812842
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.